21/11/2007
London, UK – 21 November, 2007: ReGen Therapeutics Plc (the ‘Company’) announces that it has today received notifications from three of its directors that they have acquired additional ordinary shares in the Company. Mr Percy Lomax has acquired 12,250 ordinary shares at 40p per share and now holds 38,487 ordinary shares representing 0.375% of the current issued share capital of the Company. Mr Martin Small has acquired 12,000 ordinary shares at 40p per share and now holds 45,820 ordinary shares representing 0.447% of the current issued share capital of the Company. Dr Peter Garrod has acquired 10,000 ordinary shares at 41p per share and now holds 757,500 ordinary shares representing 7.38% of the current issued share capital of the Company.
Executive Chairman Percy Lomax commented ‘These purchases demonstrate the Directors confidence in the Company and its future.’
For further information, please contact:
Andrew Marshall
Greycoat Communications
Tel No 020 7960 6007
Percy Lomax – Executive Chairman
ReGen Therapeutics Plc
Tel No 020 7153 4920
Direct No 020 8504 2156
Roland Cornish
Beaumont Cornish Limited
Tel No 020 7628 3396
Nick Bealer
King & Shaxson Capital Limited
Tel No 020 7426 5986